SCHEMBL3948407

SCHEMBL3948407

COc1cc(C(C)C(=O)N2C(=O)OCC2C(C)C)cc(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
IL6ST P40189 5/20 0.49
STAT3 P40763 1/20 0.43
IDH1 O75874 5/20 0.41
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A4 P08684 1/20 0.36
PDE4B Q07343 1/20 0.36
MAPT P10636 2/20 0.35
FKBP1A P62942 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PIK3CD O00329 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3955251 1.00 IL6ST (0.49) IL6STSTAT3IDH1CYP1A2CYP2C9
SCHEMBL3955785 1.00 IL6ST (0.49) IL6STSTAT3IDH1CYP1A2CYP2C9
SCHEMBL3948400 1.00 IL6ST (0.49) IL6STSTAT3IDH1CYP1A2CYP2C9
SCHEMBL5109568 0.87 IDH1 (0.52) IL6STSTAT3IDH1
SCHEMBL14032396 0.87 IDH1 (0.52) IL6STSTAT3IDH1
SCHEMBL5109565 0.87 IDH1 (0.52) IL6STSTAT3IDH1
SCHEMBL23162452 0.85 IL6ST (0.48) IL6STSTAT3IDH1PIK3CD
SCHEMBL15515367 0.85 IL6ST (0.48) IL6STSTAT3IDH1PIK3CD
SCHEMBL15506109 0.85 IL6ST (0.48) IL6STSTAT3IDH1PIK3CD
SCHEMBL19719544 0.84 FKBP5 (0.50) IL6STSTAT3IDH1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776404-B1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIV CONNECTICUT (US) 2016-07-06 EP disclosed
US-8853228-B2 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase UNIVERSITY OF CONNECTICUT (US) 2014-10-07 US disclosed
EP-2776404-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE University of Connecticut (US) 2014-09-17 EP disclosed
WO-2013070620-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIVERSITY OF CONNECTICUT (US) 2013-05-16 WO disclosed
US-8426432-B2 Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties UNIVERSITY OF CONNECTICUT (US) 2013-04-23 US disclosed
US-20120196859-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIVERSITY OF CONNECTICUT 2012-08-02 US disclosed
US-20090105287-A1 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties UNIVERSITY OF CONNECTICUT (US) 2009-04-23 US disclosed
WO-2009025919-A2 5-PROPARGYL-PYRIMIDINE DERIVATIVES AS INHIBITORS OF DIHYDROFOLATE REDUCTASE WITH ANTIBACTERIAL ANTIPROTOZOAL, ANTIFUNGAL AND ANTICANCER PROPERTIES UNIVERSITY OF CONNECTICUT (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105287-A1 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties DHFR, DPYD, DHODH IL6ST 3481/4885STAT3 4670/4885IDH1 68/4885
US-20120196859-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE DHFR, DPYD, DHODH IL6ST 3125/4885STAT3 4720/4885IDH1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.